N/A
Completed N=156
Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)
HIV · Disclosure
Source: ClinicalTrials.gov NCT03414372 ↗
Enrolled (actual)
156
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcomePrimary: Number of Participants With Suppressed Viral Load — 29; 31; 30 Participants
Summary
Tough Talks is a virtual reality based HIV disclosure intervention that allows HIV+ individuals to practice disclosing to romantic partners. Tough Talks allows participants to have the opportunity to practice disclosing using a variety of strategies and experience different outcomes including acceptance, confusion, lack of HIV knowledge, and rejection.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Suppressed Viral Load |
29; 31; 30 | — |
| SECONDARY Number of Participants Who Had Condomless Anal Intercourse With a Potentially Susceptible Partner |
11; 6; 8 | — |
| SECONDARY Mean Intention to Disclose Score |
1.45; 1.33; 1.15 | — |
| SECONDARY Mean Disclosure Self-Efficacy Score |
22.89; 23.03; 25.64 | — |
| SECONDARY Mean Consequences of Disclosure (Cost) Score |
23.40; 24.07; 19.20 | — |
| SECONDARY Mean Consequences of Disclosure (Rewards) Score |
32.22; 34.18; 34.31 | — |
| SECONDARY Mean Disclosure Self-Regulation (Family) Score |
2.57; 2.51; 2.59 | — |
| SECONDARY Mean Disclosure Self-Regulation (Peers) Score |
2.49; 2.33; 2.67 | — |
| SECONDARY Mean Disclosure Self-Regulation (Sexual Partners) Score |
2.08; 1.68; 1.71 | — |
| SECONDARY Mean Disclosure Outcome Expectations (Self-Evaluative) Score |
— | — |
| SECONDARY Mean Disclosure Outcome Expectations (Hedonistic) Score |
— | — |
Eligibility Criteria
Inclusion Criteria
- 16-29 years
- assigned male at birth
- male identified
- HIV infected
- Owns a mobile device or has access to a laptop or desktop computer
- able to understand, read, and speak English
- Reports 1 or more episodes of anal intercourse with a male partner in the last 6 months
Exclusion Criteria
- HIV negative
- assigned female at birth
- 15 or younger
- 30 or older
Data sourced from ClinicalTrials.gov (NCT03414372). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.